Cargando…
17-AAG Kills Intracellular Leishmania amazonensis while Reducing Inflammatory Responses in Infected Macrophages
BACKGROUND: Leishmaniasis is a neglected endemic disease with a broad spectrum of clinical manifestations. Pentavalent antimonials have been the treatment of choice for the past 70 years and, due to the emergence of resistant cases, the efficacy of these drugs has come under scrutiny. Second-line dr...
Autores principales: | Petersen, Antonio Luis de Oliveira Almeida, Guedes, Carlos Eduardo Sampaio, Versoza, Carolina Leite, Lima, José Geraldo Bomfim, de Freitas, Luiz Antônio Rodrigues, Borges, Valéria Matos, Veras, Patrícia Sampaio Tavares |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496716/ https://www.ncbi.nlm.nih.gov/pubmed/23152914 http://dx.doi.org/10.1371/journal.pone.0049496 |
Ejemplares similares
-
An In Vitro Model of Antibody-Enhanced Killing of the Intracellular Parasite Leishmania amazonensis
por: Gibson-Corley, Katherine N., et al.
Publicado: (2014) -
Cell-to-cell transfer of Leishmania amazonensis amastigotes is mediated by immunomodulatory LAMP-rich parasitophorous extrusions
por: Real, Fernando, et al.
Publicado: (2014) -
Chemotherapeutic Potential of 17-AAG against Cutaneous Leishmaniasis Caused by Leishmania (Viannia) braziliensis
por: Santos, Diego M., et al.
Publicado: (2014) -
Successful treatment of diffuse cutaneous leishmaniasis caused by Leishmania amazonensis()()
por: Sampaio, Raimunda Nonata Ribeiro, et al.
Publicado: (2021) -
Encapsulation of the HSP-90 Chaperone Inhibitor 17-AAG in Stable Liposome Allow Increasing the Therapeutic Index as Assessed, in vitro, on Leishmania (L) amazonensis Amastigotes-Hosted in Mouse CBA Macrophages
por: Petersen, Antonio Luis de Oliveira Almeida, et al.
Publicado: (2018)